
Jason Michael Nolan
Examiner (ID: 16926)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1623, 1626 |
| Total Applications | 709 |
| Issued Applications | 442 |
| Pending Applications | 91 |
| Abandoned Applications | 194 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4887725
[patent_doc_number] => 20080262057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Diarylisoxazolines'
[patent_app_type] => utility
[patent_app_number] => 12/148540
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10695
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148540 | Diarylisoxazolines | Apr 17, 2008 | Abandoned |
Array
(
[id] => 4758853
[patent_doc_number] => 20080311079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease'
[patent_app_type] => utility
[patent_app_number] => 12/082668
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15440
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082668
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082668 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Apr 9, 2008 | Issued |
Array
(
[id] => 232841
[patent_doc_number] => 07598266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Fused heterocyclic derivatives as PPAR modulators'
[patent_app_type] => utility
[patent_app_number] => 12/099929
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54691
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12099929
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/099929 | Fused heterocyclic derivatives as PPAR modulators | Apr 8, 2008 | Issued |
Array
(
[id] => 6595369
[patent_doc_number] => 20100130749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/594414
[patent_app_country] => US
[patent_app_date] => 2008-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21346
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594414 | Methods for the production of C-8 lactam lactone compounds | Mar 31, 2008 | Issued |
Array
(
[id] => 6027023
[patent_doc_number] => 20110054186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'PROCESS FOR EPROSARTAN INTERMEDIATE'
[patent_app_type] => utility
[patent_app_number] => 12/594227
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4770
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594227 | PROCESS FOR EPROSARTAN INTERMEDIATE | Mar 30, 2008 | Abandoned |
Array
(
[id] => 7545485
[patent_doc_number] => 08053457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => '3-imidazolyl-indoles for the treatment of proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 12/593721
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58144
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593721 | 3-imidazolyl-indoles for the treatment of proliferative diseases | Mar 26, 2008 | Issued |
Array
(
[id] => 6638746
[patent_doc_number] => 20100173968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'SUB-TYPE SELECTIVE AZABICYCLOALKANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/593779
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24657
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173968.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593779
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593779 | Sub-type selective azabicycloalkane derivatives | Mar 26, 2008 | Issued |
Array
(
[id] => 6519171
[patent_doc_number] => 20100217012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONES'
[patent_app_type] => utility
[patent_app_number] => 12/532937
[patent_app_country] => US
[patent_app_date] => 2008-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20815
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20100217012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532937 | Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones | Mar 25, 2008 | Issued |
Array
(
[id] => 6577522
[patent_doc_number] => 20100273848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'IMINOPYRROLIDONE THIOL AMINO ACID CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/593143
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11055
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593143 | IMINOPYRROLIDONE THIOL AMINO ACID CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Mar 13, 2008 | Abandoned |
Array
(
[id] => 6455742
[patent_doc_number] => 20100105727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/531677
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22933
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531677 | NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF | Mar 13, 2008 | Abandoned |
Array
(
[id] => 6497521
[patent_doc_number] => 20100093975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'IMIDAZOLIUM-TYPE IONIC OLIGOMERS'
[patent_app_type] => utility
[patent_app_number] => 12/530890
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15942
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093975.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530890 | Imidazolium-type ionic oligomers | Mar 11, 2008 | Issued |
Array
(
[id] => 4765637
[patent_doc_number] => 20080176849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'DEACETYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/045885
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11816
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12045885
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/045885 | DEACETYLASE INHIBITORS | Mar 10, 2008 | Abandoned |
Array
(
[id] => 4875715
[patent_doc_number] => 20080149097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB'
[patent_app_type] => utility
[patent_app_number] => 12/045121
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19432
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20080149097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12045121
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/045121 | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB | Mar 9, 2008 | Abandoned |
Array
(
[id] => 6220481
[patent_doc_number] => 20100055576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/530206
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15211
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055576.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530206
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530206 | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using the same, and lithium secondary battery using the same | Mar 5, 2008 | Issued |
Array
(
[id] => 6362004
[patent_doc_number] => 20100087658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'METHODS AND INTERMEDIATES FOR SYNTHESIS OF SELECTIVE DPP-IV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/529016
[patent_app_country] => US
[patent_app_date] => 2008-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12641
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529016 | METHODS AND INTERMEDIATES FOR SYNTHESIS OF SELECTIVE DPP-IV INHIBITORS | Mar 4, 2008 | Abandoned |
Array
(
[id] => 243362
[patent_doc_number] => 07589096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Azole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/071808
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35230
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589096.pdf
[firstpage_image] =>[orig_patent_app_number] => 12071808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/071808 | Azole derivatives | Feb 25, 2008 | Issued |
Array
(
[id] => 303669
[patent_doc_number] => 07534808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Indolylmaleimide derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/034675
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10272
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534808.pdf
[firstpage_image] =>[orig_patent_app_number] => 12034675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/034675 | Indolylmaleimide derivatives | Feb 20, 2008 | Issued |
Array
(
[id] => 5515722
[patent_doc_number] => 20090216029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'PROCESS FOR THE PRODUCTION OF ATORVASTATIN CALCIUM IN AMORPHOUS FORM'
[patent_app_type] => utility
[patent_app_number] => 12/034838
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7877
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20090216029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12034838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/034838 | PROCESS FOR THE PRODUCTION OF ATORVASTATIN CALCIUM IN AMORPHOUS FORM | Feb 20, 2008 | Abandoned |
Array
(
[id] => 263832
[patent_doc_number] => 07569597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Isoindoline compounds and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 12/070322
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20489
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569597.pdf
[firstpage_image] =>[orig_patent_app_number] => 12070322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/070322 | Isoindoline compounds and methods of their use | Feb 14, 2008 | Issued |
Array
(
[id] => 5465862
[patent_doc_number] => 20090326062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'PROCESS FOR PREPARING ENTACAPONE SUBSTANTIALLY FREE OF Z-ISOMER, SYNTHESIS INTERMEDIATES THEREOF AND A NEW CRYSTALLINE FORM'
[patent_app_type] => utility
[patent_app_number] => 12/526646
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3066
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326062.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526646 | PROCESS FOR PREPARING ENTACAPONE SUBSTANTIALLY FREE OF Z-ISOMER, SYNTHESIS INTERMEDIATES THEREOF AND A NEW CRYSTALLINE FORM | Feb 12, 2008 | Abandoned |